COMT strives at promoting the design and conduction of multidisciplinary and translational research programmes aiming at identifying novel preventive measures, more accurate diagnostic platforms and tailored therapeutic approaches, such as to warrant an effective transfer of laboratory bench findings to the clinical practice. Through the support by private and public granting agencies, intimate cooperations with pharmaceutical industry and collaborative efforts with the biomedical SMEs, COMT makes a contribution towards the implementation of the personalized management of cancer patients.